---
input_text: 'Comparison of methods for early-readmission prediction in a high-dimensional
  heterogeneous covariates and time-to-event outcome framework. BACKGROUND: Choosing
  the most performing method in terms of outcome prediction or variables selection
  is a recurring problem in prognosis studies, leading to many publications on methods
  comparison. But some aspects have received little attention. First, most comparison
  studies treat prediction performance and variable selection aspects separately.
  Second, methods are either compared within a binary outcome setting (where we want
  to predict whether the readmission will occur within an arbitrarily chosen delay
  or not) or within a survival analysis setting (where the outcomes are directly the
  censored times), but not both. In this paper, we propose a comparison methodology
  to weight up those different settings both in terms of prediction and variables
  selection, while incorporating advanced machine learning strategies. METHODS: Using
  a high-dimensional case study on a sickle-cell disease (SCD) cohort, we compare
  8 statistical methods. In the binary outcome setting, we consider logistic regression
  (LR), support vector machine (SVM), random forest (RF), gradient boosting (GB) and
  neural network (NN); while on the survival analysis setting, we consider the Cox
  Proportional Hazards (PH), the CURE and the C-mix models. We also propose a method
  using Gaussian Processes to extract meaningfull structured covariates from longitudinal
  data. RESULTS: Among all assessed statistical methods, the survival analysis ones
  obtain the best results. In particular the C-mix model yields the better performances
  in both the two considered settings (AUC =0.94 in the binary outcome setting), as
  well as interesting interpretation aspects. There is some consistency in selected
  covariates across methods within a setting, but not much across the two settings.
  CONCLUSIONS: It appears that learning withing the survival analysis setting first
  (so using all the temporal information), and then going back to a binary prediction
  using the survival estimates gives significantly better prediction performances
  than the ones obtained by models trained "directly" within the binary outcome setting.'
raw_completion_output: |-
  primary_disease: Sickle-cell disease (SCD)

  medical_actions: Logistic regression; Support vector machine; Random forest; Gradient boosting; Neural network; Cox Proportional Hazards model; CURE model; C-mix model; Gaussian Processes

  symptoms: Not specified

  chemicals: Not specified

  action_annotation_relationships: Logistic regression TREATS Sickle-cell disease (SCD); Support vector machine TREATS Sickle-cell disease (SCD); Random forest TREATS Sickle-cell disease (SCD); Gradient boosting TREATS Sickle-cell disease (SCD); Neural network TREATS Sickle-cell disease (SCD); Cox Proportional Hazards model TREATS Sickle-cell disease (SCD); CURE model TREATS Sickle-cell disease (SCD); C-mix model TREATS Sickle-cell disease (SCD); Gaussian Processes TREATS Sickle-cell disease (SCD)
prompt: |+
  Split the following piece of text into fields in the following format:

  subject_extension: <A chemical or drug mentioned in the relationship between the medical action and the symptom, for example, "analgesic agent therapy" has the aspect "analgesic">
  object_extension: <An optional term describing some specific aspect of the object, e.g. "analgesic agent therapy" has the aspect "analgesic">
  subject: <The medical action. For example: blood transfusion, radiation therapy, cardiac catheterization, pulse oximetry, otoscopy>
  predicate: <The relationship type between the medical action and the symptom, usually TREATS or PREVENTS.>
  object: <A sign or symptom associated with the disease and targeted by the medical action. For example, Low serum calcitriol, hypoplasia of the thymus, chronic cough, aortic stiffness, low pulse pressure>
  qualifier: <The primary disease the relationship is about, or specifically the disease the symptom is related to. For example, Beck-Fahrner syndrome, hereditary retinoblastoma, progeria, diabetes mellitus, infectious otitis media>
  subject_qualifier: <An optional qualifier or modifier for the subject of the statement, e.g. "high dose" or "intravenously administered">
  object_qualifier: <An optional qualifier or modifier for the object of the statement, e.g. "severe" or "with additional complications">


  Text:
  Gaussian Processes TREATS Sickle-cell disease (SCD)

  ===

extracted_object:
  primary_disease: MONDO:0007374
  medical_actions:
    - Logistic regression
    - Support vector machine
    - Random forest
    - Gradient boosting
    - Neural network
    - Cox Proportional Hazards model
    - CURE model
    - C-mix model
    - Gaussian Processes
  symptoms:
    - Not specified
  chemicals:
    - Not specified
  action_annotation_relationships:
    - subject: Logistic regression
      predicate: TREATS
      object: HP:0007760
    - subject: Support vector machine
      predicate: TREATS
      object: HP:0007760
    - subject: Random forest
      predicate: TREATS
      object: HP:0007760
    - subject: Gradient boosting
      predicate: TREATS
      object: HP:0007760
    - subject: Neural network
      predicate: TREATS
      object: HP:0007760
    - subject: Cox Proportional Hazards model
      predicate: TREATS
      object: Sickle-cell disease
      qualifier: MONDO:0007374
    - subject: CURE model
      predicate: TREATS
      qualifier: MONDO:0007374
    - subject: C-mix model
      predicate: TREATS
      object: HP:0007760
    - subject: Gaussian Processes
      predicate: TREATS
      object: HP:0007760
named_entities:
  - id: MAXO:0000756
    label: transfusion
  - id: CHEBI:64357
    label: rituximab
  - id: CHEBI:35341
    label: steroids
  - id: CHEBI:81579
    label: erythropoietin
  - id: MONDO:0011382
    label: sickle cell disease
  - id: MAXO:0001077
    label: splenectomy
  - id: MAXO:0001001
    label: gene therapy
  - id: CHEBI:4027
    label: cyclophosphamide
  - id: MONDO:0000984
    label: Thalassemia
  - id: HP:0001903
    label: anemia
  - id: MAXO:0001479
    label: allogeneic hematopoietic stem cell transplantation
  - id: HP:0001744
    label: splenomegaly
  - id: HP:0031274
    label: hypovolemic shock
  - id: CHEBI:44423
    label: hydroxyurea
  - id: MONDO:0007374
    label: Sickle Cell Disease (SCD)
  - id: MAXO:0001017
    label: Vaccination
  - id: MAXO:0010030
    label: Bone marrow transplantation
  - id: HP:0001596
    label: hair loss
  - id: HP:0000789
    label: infertility
  - id: MAXO:0000647
    label: chemotherapy
  - id: MONDO:0000001
    label: disease
  - id: CHEBI:15422
    label: Adenosine triphosphate
  - id: CHEBI:19324
    label: 2,3-diphosphoglycerate
  - id: CHEBI:16856
    label: Glutathione
  - id: CHEBI:176783
    label: Vitamin C
  - id: MAXO:0010203
    label: Echocardiography
  - id: HP:0002870
    label: Obstructive sleep apnoea (OSA)
  - id: HP:0012531
    label: Pain
  - id: MAXO:0000149
    label: Hematopoietic cell transplantation (HCT)
  - id: HP:0000112
    label: Kidney disease
  - id: HP:0012594
    label: Microalbuminuria
  - id: HP:0000093
    label: Proteinuria
  - id: HP:0003774
    label: End-stage renal disease
  - id: HP:0000716
    label: depression
  - id: HP:0000739
    label: anxiety
  - id: HP:0007760
    label: Sickle cell disease (SCD)
  - id: HP:0001875
    label: neutropenia
  - id: HP:0012234
    label: agranulocytosis
  - id: CHEBI:4356
    label: desferrioxamine (DFO)
  - id: CHEBI:17941
    label: deferiprone (DFP)
  - id: CHEBI:49005
    label: deferasirox (DFX)
  - id: CHEBI:9144
    label: silymarin
  - id: CHEBI:50453
    label: desferrioxamine
  - id: CHEBI:68554
    label: deferiprone
  - id: MONDO:0019402
    label: Thalassemia major
  - id: HP:0012532
    label: chronic pain
  - id: HP:0100639
    label: erectile dysfunction
  - id: CHEBI:71940
    label: Tadalafil
  - id: HP:0001297
    label: stroke
  - id: HP:0000083
    label: Renal failure
  - id: HP:0000488
    label: Retinopathy
  - id: HP:0001081
    label: Cholelithiasis
  - id: HP:0200023
    label: Priapism
  - id: MONDO:0044348
    label: Hemoglobinopathies
  - id: CHEBI:15551
    label: Prostaglandin E2
  - id: CHEBI:18248
    label: Iron
  - id: CHEBI:30660
    label: Thyroxine
  - id: MONDO:0044033
    label: Posterior reversible encephalopathy syndrome
  - id: MAXO:0000747
    label: Hematopoietic stem cell transplantation
  - id: HP:0001923
    label: Hemolysis (reticulocytosis)
  - id: MAXO:0000068
    label: transplantation
  - id: CHEBI:16467
    label: arginine (Arg)
  - id: CHEBI:18211
    label: citrulline (Citr)
  - id: CHEBI:3638
    label: chloroquine
  - id: CHEBI:17929
    label: asymmetric dimethylarginine
  - id: MONDO:0800385
    label: Iron overload
  - id: CHEBI:6456
    label: Lidocaine
  - id: CHEBI:30413
    label: heme
  - id: MAXO:0000819
    label: Blood collection
  - id: MONDO:0013517
    label: beta-thalassemia
  - id: CHEBI:18050
    label: L-Glutamine
  - id: CHEBI:28901
    label: Busulfan
  - id: MONDO:0044753
    label: Lumbar spinal stenosis
  - id: HP:0001945
    label: Fever
  - id: HP:0002094
    label: Dyspnea
  - id: CHEBI:33281
    label: Antibiotics
  - id: HP:0006554
    label: Acute Liver Failure
  - id: HP:0001919
    label: Acute Kidney Injury
  - id: MONDO:0800198
    label: Antibodies of unknown specificity (AUS)
  - id: HP:0002289
    label: Antibodies of unknown specificity (AUS)
  - id: MAXO:0010033
    label: umbilical cord blood transplantation
  - id: CHEBI:16480
    label: Nitric Oxide
  - id: CHEBI:65308
    label: S-nitrosothiol (SNO)
  - id: CHEBI:17334
    label: Penicillin
  - id: HP:0003287
    label: Mitochondrial dysfunction
  - id: HP:0025464
    label: Oxidative stress
  - id: CHEBI:17287
    label: Phosphocreatine
  - id: CHEBI:24838
    label: Inorganic phosphate
  - id: CHEBI:27226
    label: Uric acid
  - id: CHEBI:50443
    label: hematopoietic stem cell (HSC) transplantation
  - id: CHEBI:32599
    label: magnesium sulphate
  - id: CHEBI:25107
    label: magnesium
  - id: MAXO:0000601
    label: Dialysis
  - id: HP:0100820
    label: Glomerulopathy
  - id: HP:0000790
    label: Hematuria
  - id: HP:0001635
    label: heart failure
  - id: HP:0100543
    label: Cognitive deficits
  - id: MONDO:0004979
    label: Asthma
  - id: CHEBI:119915
    label: fentanyl
  - id: CHEBI:29016
    label: arginine
  - id: MAXO:0000618
    label: Fluid replacement therapy
  - id: CHEBI:35480
    label: analgesics
  - id: CHEBI:135949
    label: Ambrisentan
  - id: CHEBI:80240
    label: Endothelin-1
